A phase I clinical trial of intrathecal injection of allogeneic CAR-γδT cells targeting B7H3 for the treatment of patients with recurrent glioblastoma

Authors
Category Primary study
JournalANNALS OF ONCOLOGY
Year 2024
This article has no abstract
Epistemonikos ID: f5b01372f64a27c0549882e2c6d2b82f95b1f733
First added on: Feb 19, 2025